Telpha INC specialized in providing complete marketing services of healthcare therapies in various therapeutic categories. Telpha has evolved as a reliable marketing provider with customer-centric approach since its inception in 2008.
- Home
- About Us
About Us
Telpha- Key Milestones
◉ Jan 2008- Organization incorporated under the Cambodian Laws
◉ May 2008-Intiated marketing & distribution activities in Cambodia
◉ June 2010- Launch of Marketing Activities in Myanmar
◉ Jan 2011- Joint Diabetic Care Initiatives with Novo– Nordisk in Cambodia . Achieved Pan Country Operations in Myanmar and Cambodia
◉ Jan 2012- Strategic JV with Reliv health care in Myanmar
◉ Jan 2013- Cardiabet division launched with focus in cardiology & diabetes
◉ Nov 2014- Critical care division launched with focus in Nephro/ Cardiac ,critical care segments
◉ 2015 Diacare division Launched to provide Complete solutions in Diabetes
◉ 2015 – Vestel Lifes Sciences- Launched to provide solutions in Women & Child Health care
◉ 2016- Hepacare – launched to provide complete solutions in Hepatic care
Telpha - Presence in ASEAN – Marketing
Cambodia
Field force of 62medical reps/ 4 expats & 9 supervisors present all over the country ( in Eight specialty divisions) & an extended trading wing
Myanmar
Team of 65 & 3 Expats – thru RV-TELPHA
Vietnam
Team of 77 marketing professional present through our partner company Thru partner company Reliv Health care
Unique positioning – A sure way of Success
◉ Telpha has attained key positions in cardiology/ Hepatology/ Pain Management & diabetes
◉ Telpha is a major player in the antibiotic market with a complete ranges of oral and injectable antibiotics available ( Penems/Cephalosporins/ Quinilones)
◉ Telpha is a major player in treatment of emergency cares in cardiology/ bleeding/ dialysis treatments etc.
◉ Telpha in 2017- will Launch niche products in Oncology/ Gynecology/Paediatric / Dental care
2018- New Initiatives
◉ Launch Of Oncocare – Entry to oncology segment
◉ Extend Critical care range ( Darbopoetin)
◉ Over 50 products to be launched in Diabetes/ Cardiology/Gastro
◉ VELFA– Sofos+ Velpatasivir – PAN genotype treatment
◉ Jan 2008- Organization incorporated under the Cambodian Laws
◉ May 2008-Intiated marketing & distribution activities in Cambodia
◉ June 2010- Launch of Marketing Activities in Myanmar
◉ Jan 2011- Joint Diabetic Care Initiatives with Novo– Nordisk in Cambodia . Achieved Pan Country Operations in Myanmar and Cambodia
◉ Jan 2012- Strategic JV with Reliv health care in Myanmar
◉ Jan 2013- Cardiabet division launched with focus in cardiology & diabetes
◉ Nov 2014- Critical care division launched with focus in Nephro/ Cardiac ,critical care segments
◉ 2015 Diacare division Launched to provide Complete solutions in Diabetes
◉ 2015 – Vestel Lifes Sciences- Launched to provide solutions in Women & Child Health care
◉ 2016- Hepacare – launched to provide complete solutions in Hepatic care